The most common pathogenic gene of CPVT is the aniline receptor RYR2 encoding the cardiac sarcoplasmic reticulum Ca2+ release channel (about 55–65%), followed by the troponin coding gene CASQ2 (about 2%). The gene discussed is CASQ2; the disease is catecholaminergic polymorphic ventricular tachycardia.